Persistence of neutralizing antibodies a year after SARS-CoV-2 infection
Open Access
- 16 July 2021
- preprint content
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Understanding for how long antibodies persist following Severe acute respiratory coronavirus 2 (SARS-CoV-2) infection provides important insight into estimating the duration of immunity induced by infection.We assessed the persistence of serum antibodies following wild-type SARS-CoV-2 infection six and twelve months after diagnosis in 367 individuals of whom 13% had severe disease requiring hospitalization. We determined the SARS-CoV-2 spike (S-IgG) and nucleoprotein IgG concentrations and the proportion of subjects with neutralizing antibodies (NAb). We also measured the NAb titers among a smaller subset of participants (n=78) against a wild-type virus (B.1) and three variants of concern (VOCs): Alpha (B.1.1.7), Beta (B.1.351) and Delta (B.1.617.2).We found that NAb against the wild-type virus and S-IgG persisted in 89% and 97% of subjects for at least twelve months after infection, respectively. IgG and NAb levels were higher after severe infection. NAb titers were significantly lower against variants compared to the wild-type virus.Keywords
This publication has 45 references indexed in Scilit:
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After InfectionThe Journal of Infectious Diseases, 2021
- Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2The Journal of Infectious Diseases, 2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodesMed, 2021
- Evolution of antibody immunity to SARS-CoV-2Nature, 2021
- Antibody Responses One Year after Mild SARS-CoV-2 InfectionJournal of Korean Medical Science, 2021
- Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsScience, 2020
- Human neutralizing antibodies elicited by SARS-CoV-2 infectionNature, 2020
- A human monoclonal antibody blocking SARS-CoV-2 infectionNature Communications, 2020